vs
Aveanna Healthcare Holdings, Inc.（AVAH）与嘉德诺（BTSG）财务数据对比。点击上方公司名可切换其他公司
嘉德诺的季度营收约是Aveanna Healthcare Holdings, Inc.的5.7倍（$3.6B vs $621.9M）。Aveanna Healthcare Holdings, Inc.净利率更高（2.3% vs 2.2%，领先0.1%）。Aveanna Healthcare Holdings, Inc.同比增速更快（22.2% vs 16.3%）。过去两年嘉德诺的营收复合增速更高（17.4% vs 14.0%）
Aveanna Healthcare Holdings, Inc.是美国领先的家庭及社区医疗服务提供商，核心业务覆盖儿科家庭护理、成人个人照护、临终关怀、输液治疗等领域，通过覆盖全美的本地护理中心网络为各地患者提供服务，服务对象涵盖公共及私人付费群体。
嘉德诺是美国跨国医疗服务企业，位列美国企业营收榜第15位，总部位于俄亥俄州都柏林。公司主营药品与医疗产品分销，服务覆盖超10万个网点，同时生产手套、手术服、流体管理产品等医用外科用品，还运营着规模位居前列的放射性药物网络。
AVAH vs BTSG — 直观对比
营收规模更大
BTSG
是对方的5.7倍
$621.9M
营收增速更快
AVAH
高出5.9%
16.3%
净利率更高
AVAH
高出0.1%
2.2%
两年增速更快
BTSG
近两年复合增速
14.0%
损益表 — Q3 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $621.9M | $3.6B |
| 净利润 | $14.1M | $77.1M |
| 毛利率 | 32.6% | 11.6% |
| 营业利润率 | 8.6% | 3.0% |
| 净利率 | 2.3% | 2.2% |
| 营收同比 | 22.2% | 16.3% |
| 净利润同比 | 132.8% | 381.8% |
| 每股收益（稀释后） | $0.06 | $0.34 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AVAHBTSG
| Q4 25 | — | $3.6B | ||
| Q3 25 | $621.9M | $3.3B | ||
| Q2 25 | $589.6M | $3.1B | ||
| Q1 25 | $559.2M | $2.9B | ||
| Q4 24 | $519.9M | $3.1B | ||
| Q3 24 | $509.0M | $2.9B | ||
| Q2 24 | $505.0M | $2.7B | ||
| Q1 24 | $490.7M | $2.6B |
净利润AVAHBTSG
| Q4 25 | — | $77.1M | ||
| Q3 25 | $14.1M | $55.8M | ||
| Q2 25 | $27.0M | $28.2M | ||
| Q1 25 | $5.2M | $29.5M | ||
| Q4 24 | $29.2M | $16.0M | ||
| Q3 24 | $-42.8M | $-8.2M | ||
| Q2 24 | $13.9M | $19.9M | ||
| Q1 24 | $-11.2M | $-45.8M |
毛利率AVAHBTSG
| Q4 25 | — | 11.6% | ||
| Q3 25 | 32.6% | 11.8% | ||
| Q2 25 | 35.8% | 11.9% | ||
| Q1 25 | 32.8% | 11.8% | ||
| Q4 24 | 33.0% | 13.8% | ||
| Q3 24 | 31.4% | 14.0% | ||
| Q2 24 | 31.3% | 14.2% | ||
| Q1 24 | 29.7% | 14.3% |
营业利润率AVAHBTSG
| Q4 25 | — | 3.0% | ||
| Q3 25 | 8.6% | 2.6% | ||
| Q2 25 | 13.6% | 1.5% | ||
| Q1 25 | 9.3% | 1.8% | ||
| Q4 24 | 8.8% | 2.6% | ||
| Q3 24 | 6.7% | 2.0% | ||
| Q2 24 | 7.4% | 2.3% | ||
| Q1 24 | 4.7% | 0.3% |
净利率AVAHBTSG
| Q4 25 | — | 2.2% | ||
| Q3 25 | 2.3% | 1.7% | ||
| Q2 25 | 4.6% | 0.9% | ||
| Q1 25 | 0.9% | 1.0% | ||
| Q4 24 | 5.6% | 0.5% | ||
| Q3 24 | -8.4% | -0.3% | ||
| Q2 24 | 2.8% | 0.7% | ||
| Q1 24 | -2.3% | -1.8% |
每股收益（稀释后）AVAHBTSG
| Q4 25 | — | $0.34 | ||
| Q3 25 | $0.06 | $0.26 | ||
| Q2 25 | $0.13 | $0.13 | ||
| Q1 25 | $0.03 | $0.14 | ||
| Q4 24 | $0.15 | $0.11 | ||
| Q3 24 | $-0.22 | $-0.04 | ||
| Q2 24 | $0.07 | $0.10 | ||
| Q1 24 | $-0.06 | $-0.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $145.9M | $88.4M |
| 总债务越低越好 | $1.3B | $2.5B |
| 股东权益账面价值 | $9.2M | $1.9B |
| 总资产 | $1.8B | $6.4B |
| 负债/权益比越低杠杆越低 | 141.83× | 1.34× |
8季度趋势，按日历期对齐
现金及短期投资AVAHBTSG
| Q4 25 | — | $88.4M | ||
| Q3 25 | $145.9M | $140.3M | ||
| Q2 25 | $100.7M | $70.1M | ||
| Q1 25 | $71.5M | $52.3M | ||
| Q4 24 | $84.3M | $61.3M | ||
| Q3 24 | $78.5M | $36.0M | ||
| Q2 24 | $47.7M | $25.0M | ||
| Q1 24 | $42.6M | $58.0M |
总债务AVAHBTSG
| Q4 25 | — | $2.5B | ||
| Q3 25 | $1.3B | $2.5B | ||
| Q2 25 | $1.3B | $2.5B | ||
| Q1 25 | $1.3B | $2.5B | ||
| Q4 24 | $1.3B | $2.6B | ||
| Q3 24 | $1.3B | $2.7B | ||
| Q2 24 | $1.3B | $2.6B | ||
| Q1 24 | $1.3B | $2.6B |
股东权益AVAHBTSG
| Q4 25 | — | $1.9B | ||
| Q3 25 | $9.2M | $1.8B | ||
| Q2 25 | $-12.0M | $1.7B | ||
| Q1 25 | $-100.1M | $1.7B | ||
| Q4 24 | $-123.6M | $1.6B | ||
| Q3 24 | $-156.4M | $1.6B | ||
| Q2 24 | $-119.0M | $1.6B | ||
| Q1 24 | $-136.3M | $1.6B |
总资产AVAHBTSG
| Q4 25 | — | $6.4B | ||
| Q3 25 | $1.8B | $6.0B | ||
| Q2 25 | $1.8B | $5.9B | ||
| Q1 25 | $1.7B | $5.8B | ||
| Q4 24 | $1.7B | $5.9B | ||
| Q3 24 | $1.6B | $5.8B | ||
| Q2 24 | $1.7B | $5.6B | ||
| Q1 24 | $1.6B | $5.7B |
负债/权益比AVAHBTSG
| Q4 25 | — | 1.34× | ||
| Q3 25 | 141.83× | 1.38× | ||
| Q2 25 | — | 1.45× | ||
| Q1 25 | — | 1.50× | ||
| Q4 24 | — | 1.58× | ||
| Q3 24 | — | 1.65× | ||
| Q2 24 | — | 1.63× | ||
| Q1 24 | — | 1.64× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $33.2M | $231.6M |
| 自由现金流经营现金流 - 资本支出 | — | $193.9M |
| 自由现金流率自由现金流/营收 | — | 5.5% |
| 资本支出强度资本支出/营收 | — | 1.1% |
| 现金转化率经营现金流/净利润 | 2.36× | 3.00× |
| 过去12个月自由现金流最近4个季度 | — | $394.7M |
8季度趋势，按日历期对齐
经营现金流AVAHBTSG
| Q4 25 | — | $231.6M | ||
| Q3 25 | $33.2M | $107.9M | ||
| Q2 25 | $51.6M | $49.1M | ||
| Q1 25 | $-8.6M | $101.6M | ||
| Q4 24 | $13.4M | $90.6M | ||
| Q3 24 | $29.4M | $27.2M | ||
| Q2 24 | $1.8M | $-15.2M | ||
| Q1 24 | $-12.0M | $-78.9M |
自由现金流AVAHBTSG
| Q4 25 | — | $193.9M | ||
| Q3 25 | — | $92.2M | ||
| Q2 25 | — | $24.7M | ||
| Q1 25 | — | $84.0M | ||
| Q4 24 | — | $75.3M | ||
| Q3 24 | — | $7.2M | ||
| Q2 24 | — | $-39.0M | ||
| Q1 24 | — | $-100.7M |
自由现金流率AVAHBTSG
| Q4 25 | — | 5.5% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 2.9% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | -1.4% | ||
| Q1 24 | — | -3.9% |
资本支出强度AVAHBTSG
| Q4 25 | — | 1.1% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 0.9% | ||
| Q1 24 | — | 0.8% |
现金转化率AVAHBTSG
| Q4 25 | — | 3.00× | ||
| Q3 25 | 2.36× | 1.93× | ||
| Q2 25 | 1.91× | 1.74× | ||
| Q1 25 | -1.66× | 3.44× | ||
| Q4 24 | 0.46× | 5.66× | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.13× | -0.76× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AVAH
| Private Duty Services | $514.4M | 83% |
| Home Health And Hospice | $62.4M | 10% |
| Medical Solutions | $45.1M | 7% |
BTSG
| Medicare D | $1.1B | 32% |
| Commercial Insurance | $879.8M | 25% |
| Medicare C | $641.2M | 18% |
| Provider Services | $394.2M | 11% |
| Medicaid | $301.4M | 8% |
| Medicare A | $150.5M | 4% |
| Private And Other | $44.0M | 1% |
| Medicare B | $19.5M | 1% |
| Pharmacy Solutions And Provider Services Segments | $19.0M | 1% |
